BIOMARKER:

B2M-H

Entrez ID:

Related biomarkers:

‹

›

B2M-H B2M-H	Chronic Lymphocytic Leukemia CLL	B2M-H B2M-H	Chronic Lymphocytic Leukemia CLL	ibrutinib Resistant: C3 – Early Trials	ibrutinib Resistant: C3 – Early Trials
B2M-H B2M-H	Chronic Lymphocytic Leukemia CLL	B2M-H B2M-H	Chronic Lymphocytic Leukemia CLL	venetoclax + ibrutinib Sensitive: C3 – Early Trials	venetoclax + ibrutinib Sensitive: C3 – Early Trials
B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	Immunomodulator Resistant: C3 – Early Trials	Immunomodulator Resistant: C3 – Early Trials
B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	Proteasome inhibitor + Immunomodulator Resistant: C3 – Early Trials	Proteasome inhibitor + Immunomodulator Resistant: C3 – Early Trials
B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	B2M-H B2M-H	Multiple Myeloma Multiple Myeloma	Proteasome inhibitor Resistant: C3 – Early Trials	Proteasome inhibitor Resistant: C3 – Early Trials